Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KT185 is an orally-bioavailable and brain-penetrant ABHD6 inhibitor (IC50: 0.21 nM in Neuro2A cells).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 233.00 | |
10 mg | 35 days | $ 415.00 | |
25 mg | 35 days | $ 913.00 | |
50 mg | 35 days | $ 1,590.00 |
Description | KT185 is an orally-bioavailable and brain-penetrant ABHD6 inhibitor (IC50: 0.21 nM in Neuro2A cells). |
Targets&IC50 | ABHD6:0.21 nM |
Molecular Weight | 519.64 |
Formula | C32H33N5O2 |
CAS No. | 1472640-86-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KT185 1472640-86-0 Others KT-185 KT 185 inhibitor inhibit